There are 3397 resources available
244MO - A phase II trial targeting disseminated dormant tumor cells with hydroxychloroquine, everolimus or the combination to prevent recurrent breast cancer (“CLEVER”)
Presenter: Angela DeMichele
Session: Mini oral session - Breast cancer, early stage
Resources:
Abstract
Slides
Webcast
Invited Discussant 243MO and 244MO
Presenter: Ava Kwong
Session: Mini oral session - Breast cancer, early stage
Resources:
Slides
Webcast
Presentation by Expert
Presenter: Irene Braña
Session: Antibody drug conjugates: Current data and future role in drug development
Resources:
Slides
Webcast
Presentation by Expert
Presenter: Silvia Formenti
Session: Molecular evolution of brain metastases and therapeutic implications
Resources:
Slides
Webcast
Discussion led by Chair
Presenter: Giuseppe Minniti
Session: Molecular evolution of brain metastases and therapeutic implications
Resources:
Slides
Webcast
A surgeon’s perspective
Presenter: Peter Dubsky
Session: The positive sentinel lymph node: What does it mean for treatment?
Resources:
Slides
Webcast
Discussion led by Chair
Presenter: Sarat Chandarlapaty
Session: Antibody drug conjugates: Current data and future role in drug development
Resources:
Webcast
A medical oncologist’s perspective
Presenter: Evandro de Azambuja
Session: The positive sentinel lymph node: What does it mean for treatment?
Resources:
Slides
Webcast
A radiation oncologist’s perspective
Presenter: Philip Poortmans
Session: The positive sentinel lymph node: What does it mean for treatment?
Resources:
Slides
Webcast
Discussion
Presenter: All Speakers
Session: The positive sentinel lymph node: What does it mean for treatment?
Resources:
Slides
Webcast